Immune profiling of donor and recipient γδ T cells after human intestinal transplantation reveals their roles in lymphohematopoietic graft-versus-host responses and graft rejection
Nathan Suek1,2, Kevin Crosby1,2, Katherine D Long1, Tyla Young1, Zicheng Wang3, Constanza Bay Muntnich1, Alaka Gorur1,2, Wenyu Jiao1, Rebecca Jones1, Qi Yan4, Yufeng Shen3, Prakash Stawani5, Joshua Weiner1,6, Mercedes Martinez5, Tomoaki Kato6, Jianing Fu1,2.
1Columbia Center for Translational Immunology, Columbia University, New York, NY, United States; 2Department of Medicine, Columbia University, New York, NY, United States; 3Department of Systems Biology, Columbia University, New York, NY, United States; 4Department of Obstetrics and Gynecology, Columbia University, New York, NY, United States; 5Department of Pediatrics, Columbia University, New York, NY, United States; 6Department of Surgery, Columbia University, New York, NY, United States
Innate- and adaptive-like features of human γδ T cells are associated with Vγ9+δ2+ and non-Vγ9δ2 clonotypes, respectively. Despite their presence in the blood and many organs, the role of γδ T cells in transplantation is unclear.
We performed phenotypic and clonal tracking of donor- and recipient-derived γδ T cells after human intestinal transplantation (ITx) in blood, intestinal graft and bone marrow (BM) by integrating flow cytometry and sequencing platforms.
We previously demonstrated that donor T-cell blood macrochimerism (peak level ≥4%) is associated with less rejection and slower donor T cell replacement by the recipient in the ileal graft. This is due to the migration of graft-derived graft-versus-host (GvH)-reactive donor αβ T cells into the recipient blood and BM to mediate lymphohematopoietic GvH responses (LGVHR) which counteract the host-versus-graft response. Here we found that the level of blood γδ T cell chimerism correlated with total T cell chimerism (n=19). Donor γδ T cells were detected in recipient BM between post-operative day (POD)105–357. Single-cell RNA profiling of BM-infiltrating donor γδ T cells from 3 patients with pediatric donors revealed both Vδ1- and Vδ2-dominant clonotypes with cytotoxic effector T cell (Teff) phenotypes. In one patient, the top-dominant donor clone (Vγ8Vδ1) detected during peak blood T cell chimerism (POD8–20) was also predominant in recipient BM on POD126, with high cytotoxic but low proliferation gene expression. BM-infiltrating donor δ2+ T cells were dominated by sequences with zero N-additions that likely originated during fetal life and were shared across pediatric (n=6), but not adult donors (n=5), suggesting an age-related distribution and migration pattern. With recipient γδ T cells, regardless of macrochimerism status, turnover dynamics were more rapid in patients with younger donors. Graft-repopulating recipient γδ T cells gradually acquired resident-memory (TRM) phenotypes with “private” non-Vγ9δ2 clonotypes. Single-cell profiling of recipient γδ T cells from 2 quiescent and 4 rejecting intestinal grafts late post-Tx were enriched for interchangeable Teff/TRM clusters, with higher cytotoxic Teff gene expression during rejection. In one patient, the top-dominant Vδ2 sequence (mainly Vγ5δ2) in the blood during quiescence was found at low frequencies in early quiescent graft but as the top-dominant sequence in later rejecting graft, suggesting an active exchange between the blood and graft during rejection. TCR distance analysis suggested that this top-dominant sequence unlikely recognizes MICA or CD1d, but has structural similarity with some TCRδs apparently stimulated by cytokines produced by autologous αβ T cells.
Donor γδ T cells may influence LGVHR and blood chimerism, while recipient γδ T cells may affect rejection after ITx.
[1] gamma delta T cell
[2] human intestinal transplantation
[3] lymphohematopoietic graft-versus-host responses
[4] graft rejection